Education
- PhD, 2015, Case Western Reserve University
- BS, 2010, Biochemistry, Marquette University
Research Summary
Our lab studies genetic and epigenetic variation that contributes to human disease by disrupting gene expression programs. We utilize biological insights into the mechanisms of gene regulation in order to determine the impact of disease-associated variants on cellular function. We aim to identify actionable insights into disease pathogenesis by studying the confluence of genetic and epigenetic risk factors of human diseases, including multiple sclerosis and opioid use disorder.Awards
- NIH Director's Pioneer Award Program Avenir Award, 2017
Key Publications
- Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS. Factor, DC, Barbeau, AM, Allan, KC, Hu, LR, Madhavan, M, Hoang, AT, Hazel, KEA, Hall, PA, Nisraiyya, S, Najm, FJ et al.. 2020. Cell 181, 382-395.e21.
doi: 10.1016/j.cell.2020.03.002PMID:32246942 - Modeling disease risk through analysis of physical interactions between genetic variants within chromatin regulatory circuitry. Corradin, O, Cohen, AJ, Luppino, JM, Bayles, IM, Schumacher, FR, Scacheri, PC. 2016. Nat Genet 48, 1313-1320.
doi: 10.1038/ng.3674PMID:27643537 - Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Corradin, O, Saiakhova, A, Akhtar-Zaidi, B, Myeroff, L, Willis, J, Cowper-Sal lari, R, Lupien, M, Markowitz, S, Scacheri, PC. 2014. Genome Res 24, 1-13.
doi: 10.1101/gr.164079.113PMID:24196873
Recent Publications
Multimedia